Open AccessCost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial
Author(s) -
Lise Jamieson,
Celicia Serenata,
Lebogang Makhubele,
Simiso Sokhela,
Nkuli Mashabane,
Godspower Akpomiemie,
Johnson Lf,
W D Francois Venter,
Gesine MeyerRath
Publication year - 2021
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000003068
Subject(s) - dolutegravir , tenofovir alafenamide , emtricitabine , medicine , efavirenz , cost effectiveness , regimen , human immunodeficiency virus (hiv) , clinical trial , viral load , antiretroviral therapy , virology , risk analysis (engineering)